What is SYK's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 118.92B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for SYK?

P/E (TTM) is 34.23 and 52-week range is $267.00 to $389.33 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s SYK figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for SYK?

The company profile lists revenue (TTM) near $26.03B, net income (TTM) near $3.59B, EPS (TTM) near $9.39 when available from the market-data feed. Figures are informational and may lag live markets.

Does SYK show a dividend on Chartloom?

The overview lists dividend per share (TTM) near $3.48, yield near 1.07%, ex-dividend date Sep 30, 2026 when those figures are present. Dividend history is compiled from vendor data, not a distribution notice.

Where is Stryker Corporation based, and what identifiers does Chartloom list?

The company context section lists headquarters in Portage, Michigan, US, 380.7M shares outstanding, ISIN US8636671013 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Stryker Corporation

$SYK

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

Overview Charts AI Summary Financials Valuation

Profile

Read AI summary

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. The company is headquartered in Portage, Michigan and currently employs 56,000 full-time employees. The company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics primarily include implants used in total joint replacements, such as hip, knee and shoulder, and others. The company offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs. The company is also focused on treating calcified arterial disease.

Employees

56,000

Website

www.stryker.com/

IPO

1980-03-17

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (price / listing EPS)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

NEW YORK STOCK EXCHANGE, INC.

ISIN

US8636671013

Headquarters

Portage, Michigan, US

Shares outstanding

380.7M

NAICS sector

Manufacturing

Institutional ownership

82.87%

Browse other companiesFree AI scores and summaries for more stocks